軟骨修復/再生の世界市場分析:治療法別(体細胞由来、体細胞非由来)、用途別(硝子軟骨、線維軟骨)、治療別(緩和、因性修復刺激)、状況別(膝軟骨修復)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Cartilage Repair/Regeneration Market Analysis By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Site (Knee Cartilage Repair), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased database
1.1.2. GVR’s internal database
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Primary Research
1.4.1. List of primary sources
1.5. Approaches for Market Estimation
1.5.1. Approach 1: Commodity flow & bottom-up approach
1.5.2. Approach 2: Top-down and parent market analysis
Chapter 2. Executive Summary
2.1. Market Snapshot, 2016
Chapter 3. Cartilage Repair/Regeneration Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Market Restraint Analysis
3.4. Penetration & Growth Prospect Mapping
3.5. SWOT Analysis, by Factor
3.5.1. Political
3.5.2. Economic
3.5.3. Technological
3.6. Industry Analysis – Porter’s
Chapter 4. Cartilage Repair/Regeneration Market: Treatment Modality Estimates & Trend Analysis
4.1. Treatment Modality Movement Analysis & Market Share, 2016 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following treatment modality:
4.2.1. Cell-based
4.2.1.1. Chondrocyte transplantation
4.2.1.1.1. Chondrocyte transplantation market estimates and forecasts, 2014 to 2025
4.2.1.2. Growth factor pharmacology
4.2.1.2.1. Growth factor technology market estimates and forecasts, 2014 to 2025
4.2.2. Non-Cell-based
4.2.2.1. Tissue scaffolds
4.2.2.1.1. Tissue scaffolds market estimates and forecasts, 2014 to 2025
4.2.2.2. Cell-free composites
4.2.2.2.1. Cell-free composites market estimates and forecasts, 2014 to 2025
Chapter 5. Cartilage Repair/Regeneration Market: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2016 & 2025
5.2. Market Size Estimates & Forecasts for the following application:
5.2.1. Hyaline cartilage
5.2.1.1. Hyaline cartilage market estimates and forecasts, 2014 to 2025
5.2.2. Fibrocartilage
5.2.2.1. Fibrocartilage market estimates and forecasts, 2014 to 2025
Chapter 6. Cartilage Repair/Regeneration Market: Treatment Type Estimates & Trend Analysis
6.1. Treatment Type Analysis & Market Share, 2016 & 2025
6.2. Market Size Estimates & Forecasts for the following treatment type:
6.2.1. Palliative
6.2.1.1. Viscosupplementation
6.2.1.1.1. Viscosupplementation market estimates and forecasts, 2014 to 2025
6.2.1.2. Debridement & Lavage
6.2.1.2.1. Debridement & lavage market estimates and forecasts, 2014 to 2025
6.2.2. Intrinsic repair stimulus
6.2.2.1. Intrinsic repair stimulus market estimates and forecasts, 2014 to 2025
Chapter 7. Cartilage Repair/Regeneration Market: Site Estimates & Trend Analysis
7.1. Site Movement Analysis & Market Share, 2016 & 2025
7.2. Market Size Estimates & Forecasts for the following site:
7.2.1. Knee cartilage repair
7.2.1.1. Knee cartilage repair market estimates and forecasts, 2014 to 2025
7.2.2. Other
7.2.2.1. Other market estimates and forecasts, 2014 to 2025
Chapter 8. Cartilage Repair/Regeneration Market: Regional Estimates & Trend Analysis
8.1. Regional Movement Analysis & Market Share, 2016 & 2025
8.2. North America
8.2.1. U.S.
8.2.1.1. U.S. revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.2.1.2. U.S. revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.2.1.3. U.S. revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.2.1.4. U.S. revenue estimates and forecasts, by technique 2014 – 2025 (USD Million)
8.2.2. Canada
8.2.2.1. Canada revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.2.2.2. Canada revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.2.2.3. Canada revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.2.2.4. Canada revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.3. Europe
8.3.1. UK
8.3.1.1. UK revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.3.1.2. UK revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.3.1.3. UK revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.3.1.4. UK revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.3.2. Germany
8.3.2.1. Germany revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.3.2.2. Germany revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.3.2.3. Germany revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.3.2.4. Germany revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.4. Asia Pacific
8.4.1. Japan
8.4.1.1. Japan revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.4.1.2. Japan revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.4.1.3. Japan revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.4.1.4. Japan revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.4.2. China
8.4.2.1. China revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.4.2.2. China revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.4.2.3. China revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.4.2.4. China revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.5. Latin America
8.5.1. Brazil
8.5.1.1. Brazil revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.5.1.2. Brazil revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.5.1.3. Brazil revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.5.1.4. Brazil revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.5.2. Mexico
8.5.2.1. Mexico revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.5.2.2. Mexico revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.5.2.3. Mexico revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.5.2.4. Mexico revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.6. MEA
8.6.1. South Africa
8.6.1.1. South Africa revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.6.1.2. South Africa revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.6.1.3. South Africa revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.6.1.4. South Africa revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
Chapter 9. Competitive Landscape
9.1. Strategy Framework
9.2. Company Profiles
9.2.1. Zimmer Biomet
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Stryker Corporation
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Depuy Synthes
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Smith & Nephew plc
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Vericel Corporation
9.2.5.1. Company overview
9.2.5.2. Financial Performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Osiris Therapeutics Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. B. Braun Melsungen AG
9.2.7.1. Company overview
9.2.7.2. Financial Performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Anika Therapeutics, Inc.
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Arthrex, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Collagen Solutions Plc
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives


【レポート販売概要】

■ タイトル:軟骨修復/再生の世界市場分析:治療法別(体細胞由来、体細胞非由来)、用途別(硝子軟骨、線維軟骨)、治療別(緩和、因性修復刺激)、状況別(膝軟骨修復)、セグメント予測、2014-2025
■ 英文:Cartilage Repair/Regeneration Market Analysis By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Site (Knee Cartilage Repair), And Segment Forecasts, 2014-2025
■ 発行日:2017年5月16日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707169
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。